TherapeuticsMD, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $3.00K, a 97.16% decline year-over-year.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $21.00K, a 77.89% decline year-over-year.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $322.00, a 6.40% decline year-over-year.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $105.49K, a 1133.99% increase year-over-year.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $44.00K, a 83.82% decline from fiscal 2020.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $272.00K, a 149.54% increase from fiscal 2019.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $109.00K, a 93.46% decline from fiscal 2018.
- TherapeuticsMD, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $1.67M, a 683.67% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $44.00K 10-K · filed 2023-04-07 | |
| 2021-09-30 | $3.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $21.00K 10-Q · filed 2022-08-15 | |
| 2020-12-31 | $322.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $272.00K 10-K · filed 2022-03-23 |
| 2020-09-30 | $105.49K 10-Q · filed 2020-11-09 | $272.84K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $95.00K 10-Q · filed 2021-11-12 | $175.89K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | $72.00K 10-Q · filed 2021-11-12 | $80.89K derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | $344.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $109.00K 10-K · filed 2022-03-23 |
| 2019-09-30 | $8.55K 10-Q · filed 2020-11-09 | $538.55K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $637.32K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $100.11K 10-Q · filed 2019-05-08 | $1.72M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-12-31 | $429.89K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.67M 10-K · filed 2020-02-24 |
| 2018-09-30 | $107.32K 10-Q · filed 2019-11-08 | $1.24M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $1.08M 10-Q · filed 2019-11-08 | $1.13M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $44.06K 10-Q · filed 2019-11-08 | $64.36K derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $212.62K 10-K · filed 2020-02-24 |
| 2017-09-30 | $255.00 10-Q · filed 2017-11-07 | $606.55K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $20.05K 10-Q · filed 2017-08-03 | $607.32K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $192.31K 10-Q · filed 2017-05-03 | $778.86K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $393.94K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.37M 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.02K 10-Q · filed 2017-11-07 | $1.62M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $191.59K 10-Q · filed 2017-08-03 | $1.72M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $786.45K 10-Q · filed 2017-05-03 | $2.01M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $642.71K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $1.23M 10-K · filed 2018-02-23 |
| 2015-09-30 | $98.48K 10-Q · filed 2015-11-05 | $620.03K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $484.14K 10-Q · filed 2015-08-07 | $549.81K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $7.21K 10-Q · filed 2015-05-07 | $312.90K derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $30.20K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $345.75K 10-K · filed 2017-02-28 |
| 2014-09-30 | $28.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2014-06-30 | $247.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | |
| 2014-03-31 | $40.05K 10-Q · filed 2015-05-07 | |
| 2013-12-31 | $30.91K 10-K · filed 2016-02-26 | |
| 2012-12-31 | $191.00K 10-K · filed 2015-03-12 | |
| 2012-09-30 | $12.46K 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $17.25K 10-K · filed 2014-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |